2Lorigados PL,Morales CL,Pavon FN,et al.Immunological disorders in epileptic patients are associated to the epileptogenic focus localization.Rev Neurol,2004,39:101-104.
3Hosokawa M,Klegeris A,Maguire J,et al.Expression of complement messenger RNAs and proteins by human oligodendroglial cells.Glia,2003,42:417-423.
4Levite M.Autoimmune in Epilepsy.Nat Immunol,2002 ,3 :500-505.
5Dambinova SA.The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy.J Neurol Sci ,1997,152:93-96.
6Dambinova SA.Monitoring of brain spiking activity and autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptors in blood serum of rats with cobalt-induced epilepsy.J Neurochem,1998,71:2088-2092.
7He XP,Patel M.Glutamate receptor GluR3 antibodies and death of cortical cells.Neuron,1998,20:153-163.
8Peltola J.Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.Neurology ,2000,55:46-50.
9Morozov SG.Autoantibodies to brain tissue antigens in epilepsy patients.Zh neuropatol Psikhiatr Im S S korsakova,1996,96:71-76.
10Verrot D,San-Maroc M,Dravet C,et al.Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy.Am J Med,199,103:33-37.
